Remote Medical International Acquires SSI Group
Remote Medical International, a global leader in workplace health and safety services for Fortune 100 corporations and government services prime contractors, announced it completed its acquisition of SSI Group on July 1. Based in the United Kingdom, SSI specializes in emergency response medical services for the oil and gas and renewable energy sectors, global risk management, and international safety.
“This acquisition is part of our strategy to aggressively expand into new markets, notably renewable energy, broaden our offerings to include risk management, and build on our leading COVID-19 services,” said Wayne Wager, CEO of Remote Medical International. “The complementary nature of our businesses adds to our ability to design bespoke solutions for our clients that save lives and improve the health of workers in diverse job sites around the world.”
Remote Medical International will leverage SSI’s years of work to provide medical and technical support for offshore wind farm and other renewable energy construction in the North Sea and North America and expand its work with large corporations working in remote and challenging locations globally. The combined expertise will produce a comprehensive range of COVID-19 medical services and solutions for businesses seeking to create safe back-to-work situations under one Remote Medical International offering.
The combined companies will deliver unparalleled quality by setting the highest standards for medical and safety personnel and clinical governance. Customers will benefit from the companies’ vast experience in offering workplace health and safety and risk management services to more than 120 countries across the globe.
“We are delighted to join the Remote Medical International team and believe that together our companies will deliver greater value to our customers through our common values of quality, agility, responsiveness, and collaboration,” said Duncan Higham, Founder and Managing Director of SSI. ”We share a passion for delivering unparalleled services and a vision of being the best remote medical provider on land and at sea.”
Mr. Higham has been named Remote Medical International’s vice president global strategy, reporting directly to Wayne Wager, CEO of Remote Medical International. Julian Rawles, formerly SSI’s commercial director, will serve as the managing director of Remote Medical International UK reporting to Paul Budak, chief operating officer. No other changes in either organization are anticipated. The terms of the acquisition were not disclosed. Visit the company’s website, https://remotemedical.com/ for more information.
About Remote Medical International
Headquartered in Seattle, Washington, Remote Medical International saves lives and protects the health and wellbeing of workers in diverse job sites from remote pipeline installations to offshore wind and maritime operations. The company has been recognized six times by Inc. 5000 as one of the fastest-growing companies in the United States and works with Fortune 100 corporations and government services prime contractors.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200715005453/en/
Contact information
Bonnie Quintanilla
Clarity Quest
bonnie@clarityqst.com
877-887-7611
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
10-Year Partnership Between ISN ® and Yara International Enhances Ongoing Commitment to Contractor Safety14.5.2025 11:00:00 EEST | Press release
ISN, the global leader in contractor and supplier information management services, celebrates 10 years of partnership with the European division of Yara International (Yara), a leading provider of crop nutrition and sustainable agricultural solutions. After a successful implementation in the Americas, Yara adopted ISNetworld across its European sites in 2015, expanding its use of the contractor management platform, streamlining processes, and improving operational efficiency. “Over the past decade, ISN has been instrumental to Yara’s contractor management processes in Norway and the Netherlands," said Steinar Bjelland, Procurement Manager at Yara. "Leveraging ISNetworld tools and services such as RAVS 360™ and acknowledgment form tracking, along with ISN’s multilingual support, has helped Yara optimise compliance, improve communication, and effectively align our protocols with industry best practices.” Headquartered in Oslo, Norway, Yara operates in more than 60 countries. Yara works t
Ares Management Opens Milan Office14.5.2025 11:00:00 EEST | Press release
Ares Management Corporation (NYSE: ARES) (“Ares”), a leading global alternative investment manager, announced today the opening of a new office in Milan, the firm’s latest office in Europe. The office will enhance Ares’ access to the Italian market, and its ability to raise and invest capital across its strategies, particularly within its European Direct Lending business, as well as the Wealth Management and European Real Estate platforms. This latest opening underscores Ares’ commitment to a highly localized approach to investing in Europe, which the firm entered in 2007 through the opening of a London office, followed by Paris, Frankfurt and Stockholm in 2009 and, most recently, Amsterdam and Madrid in 2019. Across its investment strategies, including European Direct Lending and European Real Estate, Ares has deployed over €1.6 billion to support Italian businesses and assets, as of March 31, 2025, and Ares expects to accelerate this activity in the coming years. Tyrone Cooney, Partn
Intelsat, Cubic³ Complete Vehicle Satellite Connectivity Test, Advancing Ubiquitous Connectivity Vision14.5.2025 10:00:00 EEST | Press release
Intelsat and Cubic³ have successfully completed a critical vehicle satellite connectivity test, marking a significant milestone in their joint mission to create a seamless connectivity service for all types of vehicles. The test demonstrated successful integration between Intelsat satellites and Cubic³’s software platform, showcasing how terrestrial and non-terrestrial networks can seamlessly link to deliver always-on connectivity regardless of location. “Our Memorandum of Understanding and successful test brings us closer to our vision of truly ubiquitous connectivity,” said Bruno Fromont, Intelsat Chief Technology Officer. “By combining Intelsat’s satellite expertise with Cubic³’s innovative connectivity platform, we’re creating solutions that will keep vehicles connected anywhere in the world, enabling critical functions from broadband connectivity, diagnostics to eventually supporting autonomous driving capabilities.” The successful test focused on a commercial land mobile use case
Norli Liv & Pension Modernizes Investment Operations with Clearwater Analytics14.5.2025 10:00:00 EEST | Press release
Clearwater Analytics (NYSE: CWAN), the most comprehensive technology platform for investment management, today announced that Danish pension provider, Norli Liv & Pension, part of the Norli group, has partnered with Clearwater to modernize its investment accounting, reporting and compliance operations. Clearwater will provide Norli with a single, consolidated view of all in-house and outsourced chief investment officer (OCIO) managed holdings across its public and private asset classes—enhancing investment transparency and empowering better, faster decision-making. The platform will also support regulatory compliance through automated workflows and robust, audit-ready reporting. By moving to Clearwater’s single instance, multi-tenant platform, Norli Liv & Pension will eliminate multiple legacy platforms, reduce manual work and accelerate its monthly close. The platform’s “single pane of glass” view will provide users across departments with unified access to accurate, timely data and a
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)14.5.2025 09:14:00 EEST | Press release
GSK plc (LSE/NYSE: GSK) and Boston Pharmaceuticals, a leading clinical stage biopharmaceutical company developing highly targeted therapies for patients with serious liver diseases, today announced that they have entered into an agreement under which GSK will acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa. Efimosfermin is a phase III-ready, potential best-in-class, investigational specialty medicine to treat and prevent progression of steatotic liver disease (SLD). Under the agreement, GSK will pay $1.2 billion upfront, with potential for additional success-based milestone payments totalling $800 million. Efimosfermin is a novel, once-monthly fibroblast growth factor 21 (FGF21) analog therapeutic in clinical development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), including cirrhosis, and future development in alcohol-related liver disease (ALD), both forms of SLD. Given efimosfermin’s direct antifibrotic mechanism of action and GSK’s dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom